The first patient receives an FDA-approved gene therapy for inherited retinal disease at Mass. Eye and Ear.
Award recipients to use IRIS Registry database to conduct population-based studies.
Many of the organization’s individual grants will now be open to researchers at any U.S. academic medical center.
RPB-supported researchers at the University of Southern California Roski Eye Institute conducted the human trial.
RPB hosted its fifth annual convening of organizations that fund vision research in Washington DC.
|General Info||Research Scientists & Grantees||Eye Care Specialists||Donors & Partners|